Calcipotriol / Calcipotriene
Family: Vitamin D derivatives
Status: Commercially available
Regulatory: US-DMF • CEP
Family: Vitamin D derivatives
Status: Commercially available
Regulatory: US-DMF • CEP
Family: Vitamin D derivatives
Status: Commercially available
Regulatory: US-DMF • CEP
Family: Reduced Folates
Status: Commercially available
Regulatory: US-DMF • CEP • JDMF
Family: Reduced Folates
Status: Commercially available
Regulatory: US-DMF • CEP • JDMF
Family: Reduced Folates
Status: Commercially available
Regulatory: –
Family: Reduced Folates
Status: Commercially available
Regulatory: –
Family: Vitamin D derivatives
Status: Commercially available
Regulatory: US-DMF • CEP
Family: Long-acting muscarinic antagonist
Status: Commercially available
Regulatory: –
Family: Reduced Folates
Status: Development
Regulatory: –
Family: Recombinant Protein
Status: Development
Regulatory: –
Family: Reduced Folates
Status: Commercially available
Regulatory: EU • DMF
Family: Long-acting muscarinic antagonist
Status: Registration
Regulatory: US-DMF
Indications: treatment and prevention of diarrhea (travellers, infective), dysbiosis by antibiotics.
Regulatory status: drug product (CTD + CPP from Switzerland)
Indications: treatment and prevention of acne and seborrheic dermatitis
Regulatory status: Food Supplement (EU)
Indications: treatment and prevention of dyslipidemias, obesity, metabolic syndrome.
Regulatory status: Food Supplement (EU)
Indications: treatment and prevention of Irritable Bowel Syndrome (IBS)
Regulatory status: Food for Special Medical Purposes – FSMPs (EU)
Indications: Immunity system booster
Regulatory status: Food Supplement (EU)
Family: Probiotic feed additives
Status: Commercially available
Regulatory: EU
Family: Probiotic feed additives
Status: Commercially available
Regulatory: EU
Family: Probiotic feed additives
Status: Commercially available
Regulatory: EU
Family: Probiotic feed additives
Status: Commercially available
Regulatory: EU